Given the importance of Wnt/β-catenin in the mammary gland tumorigenesis in triple negative, mesenchymal breast cancers [36], we speculate that DACT3 represents a potential therapeutic target for these carcinomas. This evidence concerns the gene DACT3 and breast cancer.